Marko Stajdohar

Marko Stajdohar currently serves as the Chief Executive Officer at SkinPharma since June 2024. Prior to this role, Stajdohar was a Key Account Manager AE at Medis from April 2022 to August 2024, where responsibilities included the distribution of Merz Aesthetics products in Croatia and surrounding countries, relationship management with key customers, and sales target achievement. From September 2014 to April 2022, Stajdohar worked at Ottobock, initially as a Product Manager focusing on prosthetics, and subsequently as a Key Account Manager SEE, where duties encompassed business development and customer support across several Southeast European markets. Stajdohar began a professional career as a Sales Specialist and also gained experience as an Estimator at Seamless Mechanical NYC from 2012 to 2013. Educational qualifications include a degree from the University of Zagreb and health-related studies at Zdravstveno Veleuciliste Zagreb.